Campbell McInnes

2.6k total citations
54 papers, 1.8k citations indexed

About

Campbell McInnes is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Campbell McInnes has authored 54 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 26 papers in Oncology and 20 papers in Cell Biology. Recurrent topics in Campbell McInnes's work include Microtubule and mitosis dynamics (19 papers), Cancer-related Molecular Pathways (19 papers) and Ubiquitin and proteasome pathways (8 papers). Campbell McInnes is often cited by papers focused on Microtubule and mitosis dynamics (19 papers), Cancer-related Molecular Pathways (19 papers) and Ubiquitin and proteasome pathways (8 papers). Campbell McInnes collaborates with scholars based in United States, Canada and Greece. Campbell McInnes's co-authors include Peter M. Fischer, Michael D. Wyatt, Mokdad Mezna, George Kontopidis, Brian D. Sykes, Brian D. Sykes, Tilman Brummer, Robert S. Hodges, Mark Thomas and Charles D. Smith and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.

In The Last Decade

Campbell McInnes

54 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Campbell McInnes United States 22 1.2k 513 365 358 313 54 1.8k
Wynne Aherne United Kingdom 27 1.5k 1.3× 509 1.0× 219 0.6× 301 0.8× 161 0.5× 58 2.3k
Swee Y. Sharp United Kingdom 25 2.0k 1.8× 750 1.5× 362 1.0× 303 0.8× 417 1.3× 45 2.8k
Andrew J. Massey United Kingdom 24 1.5k 1.3× 327 0.6× 339 0.9× 250 0.7× 227 0.7× 43 2.0k
Shiva Malek United States 23 2.2k 1.9× 774 1.5× 213 0.6× 233 0.7× 208 0.7× 35 3.1k
Thomas O’Brien United States 31 2.7k 2.3× 743 1.4× 341 0.9× 229 0.6× 364 1.2× 62 3.6k
Bi‐Ching Sang United States 18 1.2k 1.1× 711 1.4× 167 0.5× 221 0.6× 337 1.1× 30 2.2k
Olivia W. Rossanese United States 25 2.0k 1.7× 433 0.8× 218 0.6× 622 1.7× 317 1.0× 39 2.5k
Monica Schenone United States 17 2.7k 2.3× 604 1.2× 332 0.9× 134 0.4× 254 0.8× 33 3.5k
David H. Drewry United States 29 1.4k 1.2× 507 1.0× 392 1.1× 242 0.7× 612 2.0× 102 2.5k
Joseph Schoepfer Switzerland 24 1.5k 1.3× 470 0.9× 209 0.6× 111 0.3× 532 1.7× 43 2.0k

Countries citing papers authored by Campbell McInnes

Since Specialization
Citations

This map shows the geographic impact of Campbell McInnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Campbell McInnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Campbell McInnes more than expected).

Fields of papers citing papers by Campbell McInnes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Campbell McInnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Campbell McInnes. The network helps show where Campbell McInnes may publish in the future.

Co-authorship network of co-authors of Campbell McInnes

This figure shows the co-authorship network connecting the top 25 collaborators of Campbell McInnes. A scholar is included among the top collaborators of Campbell McInnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Campbell McInnes. Campbell McInnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Strebhardt, Klaus, et al.. (2025). Structural regulation of PLK1 activity: implications for cell cycle function and drug discovery. Cancer Gene Therapy. 32(6). 608–621. 2 indexed citations
2.
Çetįn, Metin, Özge Saatci, Abdol-Hossein Rezaeian, et al.. (2024). A highly potent bi-thiazole inhibitor of LOX rewires collagen architecture and enhances chemoresponse in triple-negative breast cancer. Cell chemical biology. 31(11). 1926–1941.e11. 10 indexed citations
3.
Brummer, Tilman & Campbell McInnes. (2020). RAF kinase dimerization: implications for drug discovery and clinical outcomes. Oncogene. 39(21). 4155–4169. 43 indexed citations
4.
Pearson, Russell J., David Blake, Mokdad Mezna, et al.. (2018). The Meisenheimer Complex as a Paradigm in Drug Discovery: Reversible Covalent Inhibition through C67 of the ATP Binding Site of PLK1. Cell chemical biology. 25(9). 1107–1116.e4. 11 indexed citations
5.
Liu, Shu, et al.. (2016). Benzamide capped peptidomimetics as non-ATP competitive inhibitors of CDK2 using the REPLACE strategy. Bioorganic & Medicinal Chemistry Letters. 26(15). 3754–3760. 6 indexed citations
6.
Gao, Jie, Narasimha M. Midde, Jun Zhu, et al.. (2016). Synthesis and biological evaluation of ranitidine analogs as multiple-target-directed cognitive enhancers for the treatment of Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters. 26(22). 5573–5579. 9 indexed citations
7.
McInnes, Campbell, et al.. (2015). Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors. Journal of Visualized Experiments. e52441–e52441. 2 indexed citations
8.
Wyatt, Michael D., et al.. (2014). Current assessment of polo-like kinases as anti-tumor drug targets. Expert Opinion on Drug Discovery. 9(7). 773–789. 40 indexed citations
9.
McInnes, Campbell, Zhengguan Yang, Paul A. Johnston, et al.. (2012). Targeting Subcellular Localization through the Polo-Box Domain: Non-ATP Competitive Inhibitors Recapitulate a PLK1 Phenotype. Molecular Cancer Therapeutics. 11(8). 1683–1692. 18 indexed citations
10.
Gruver, Aaron M., et al.. (2009). Functional characterization and identification of mouse Rad51d splice variants. BMC Molecular Biology. 10(1). 27–27. 12 indexed citations
11.
Kontopidis, George, et al.. (2009). Truncation and Optimisation of Peptide Inhibitors of Cyclin‐Dependent Kinase 2‐Cyclin A Through Structure‐Guided Design. ChemMedChem. 4(7). 1120–1128. 16 indexed citations
12.
McInnes, Campbell. (2007). Virtual screening strategies in drug discovery. Current Opinion in Chemical Biology. 11(5). 494–502. 322 indexed citations
13.
Kontopidis, George, Campbell McInnes, Andrew Plater, et al.. (2006). REPLACE: A Strategy for Iterative Design of Cyclin‐Binding Groove Inhibitors. ChemBioChem. 7(12). 1909–1915. 35 indexed citations
14.
Kontopidis, George, Campbell McInnes, I.W. McNae, et al.. (2006). Differential Binding of Inhibitors to Active and Inactive CDK2 Provides Insights for Drug Design. Chemistry & Biology. 13(2). 201–211. 49 indexed citations
15.
McInnes, Campbell & Peter M. Fischer. (2005). Strategies for the Design of Potent and Selective Kinase Inhibitors. Current Pharmaceutical Design. 11(14). 1845–1863. 43 indexed citations
16.
Wang, Shudong, Gavin Wood, Christopher Meades, et al.. (2004). Synthesis and biological activity of 2-anilino-4-(1H-pyrrol-3-yl) pyrimidine CDK inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(16). 4237–4240. 53 indexed citations
17.
McInnes, Campbell, Suzanne Grothé, Maureen D. O'Connor‐McCourt, & Brian D. Sykes. (2000). NMR study of the differential contributions of residues of transforming growth factor alpha to association with its receptor. Protein Engineering Design and Selection. 13(3). 143–147. 18 indexed citations
18.
McInnes, Campbell & Brian D. Sykes. (1997). Growth factor receptors: Structure, mechanism, and drug discovery. Biopolymers. 43(5). 339–366. 69 indexed citations
19.
20.
Leone‐Bay, Andrea, et al.. (1995). Microsphere Formation in a Series of Derivatized .alpha.-Amino Acids: Properties, Molecular Modeling, and Oral Delivery of Salmon Calcitonin. Journal of Medicinal Chemistry. 38(21). 4257–4262. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wynne Aherne Breakdown of academic impact, for papers by Swee Y. Sharp Breakdown of academic impact, for papers by Andrew J. Massey Breakdown of academic impact, for papers by Shiva Malek Breakdown of academic impact, for papers by Thomas O’Brien Breakdown of academic impact, for papers by Bi‐Ching Sang Breakdown of academic impact, for papers by Olivia W. Rossanese Breakdown of academic impact, for papers by Monica Schenone Breakdown of academic impact, for papers by David H. Drewry Breakdown of academic impact, for papers by Joseph Schoepfer
Rankless by CCL
2026